COR Q3 2022 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q3 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$60.1B+12.5% YoY

Gross Profit

$1.8B3.1% margin

Operating Income

$631M1.1% margin

Net Income

$407M0.7% margin

EPS (Diluted)

$1.92

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$409M

Free Cash Flow

$295M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$57.2B

Total Liabilities

$56.7B

Stockholders' Equity

$224M

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60.1B	$53.4B	+12.5%
Gross Profit	$1.8B	$1.9B	-3.4%
Operating Income	$631M	$995M	-36.6%
Net Income	$407M	$292M	+39.3%

Revenue Segments

Pharmaceutical Distribution

$52.2B87%

International Healthcare Solutions

$6.7B11%

Animal Health

$1.2B2%

Geographic Segments

U.S. Healthcare Solutions

$53.4B89%

International Healthcare Solutions

$6.7B11%